From the Qtrly "SciDev achieved a modest profit during the...

From the Qtrly

"SciDev achieved a modest profit during the quarter despite a reduction in sales during March from customers in the quarrying and coal seam gas extraction industries due to site specific reasons.
Sales to these customers are expected to resume during the current quarter. New customer sales in
the areas of liquid waste treatment and metalliferous mining were achieved during the quarter.

In relation to the OptiFlox® system, fabrication and off-site testing of the system is now in its final
stages. The commercial terms for a six-month trial of the Optiflox® system at a large NSW thermal
coal mine have been agreed, which include the receipt of licensing fees and revenue from associated
coagulant product sales. The system will be transported to the trial site in the first half of next month and should be operational shortly thereafter. Dependent upon successful trial results, further roll-outs of the OptiFlox® systems would be expected to take place in the second half of this calendar year."


Intec continues to investigate other acquisition opportunities, principally those either
complementary or supplementary to SciDev."